City State Bank’s Avanos Medical AVNS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$448 Hold
18
﹤0.01% 781
2026
Q1
$252 Hold
18
﹤0.01% 766
2025
Q4
$202 Hold
18
﹤0.01% 754
2025
Q3
$208 Hold
18
﹤0.01% 728
2025
Q2
$220 Hold
18
﹤0.01% 726
2025
Q1
$258 Hold
18
﹤0.01% 724
2024
Q4
$287 Hold
18
﹤0.01% 699
2024
Q3
$433 Hold
18
﹤0.01% 701
2024
Q2
$359 Buy
+18
New +$351 ﹤0.01% 697
2023
Q2
Sell
-18
Closed -$1K 706
2023
Q1
$1K Buy
+18
New +$523 ﹤0.01% 647
2022
Q4
Sell
-18
Closed 659
2022
Q3
$0 Hold
18
﹤0.01% 663
2022
Q2
$0 Hold
18
﹤0.01% 668
2022
Q1
$1K Hold
18
﹤0.01% 648
2021
Q4
$1K Buy
+18
New +$582 ﹤0.01% 640

Other funds holding AVNS

City State Bank's AVNS Position: Q2 2026 in Review

City State Bank held its Avanos Medical (AVNS) position steady in Q2 2026 at 18 shares worth $448. The position accounts for ﹤0.01% of the portfolio, ranked #781.

City State Bank first reported a position in AVNS in Q4 2021 and has held it in 14 quarters since. The position peaked at $1K in Q1 2023. 73 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • City State Bank held 18 shares of Avanos Medical worth $448 as of Q2 2026.
  • City State Bank left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of City State Bank's portfolio in Q2 2026, its #781 holding.
  • City State Bank first reported a position in Avanos Medical in Q4 2021 and has held it in 14 quarters since.
  • City State Bank's Avanos Medical position peaked at $1K in Q1 2023.
  • 73 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on City State Bank's 13F filing for Q2 2026, filed 14 Jul 2026.